XCMR has been granted a subcontract for $66,000 as part of Eden Park’s Phase 1 SBIR award by the Department of Energy (DOE) to support the development of human-safe, miniature Far UV-C microplasma lamps for personal protective respirators. The project is part of a broader initiative to improve pathogen protection technologies, making environments safer for healthcare workers and the general public.
This Phase 1 funding underscores the importance of XCMR’s work in developing applications of Far UV-C technology, which has the potential to revolutionize pathogen inactivation without harming human tissue. The company is focusing on integrating microplasma lamps into personal protective respirators, offering continuous, real-time protection against airborne pathogens.
The DOE’s Small Business Innovation Research (SBIR) awards are highly competitive and recognize the most promising technological advancements. XCMR’s contributions to the efforts align with DOE’s goals of promoting innovation in energy and safety technologies, marking an important milestone in the development of next-generation PPE.
This Phase 1 subcontract provides XCMR with the critical funding needed to demonstrate proof of concept for its innovative PPE design employing Far UV-C microplasma lamp technology. The successful completion of this project could pave the way for future development and scaling, potentially leading to further DOE support.
XCMR’s receipt of the DOE Phase 1 SBIR subcontract is a testament to the company’s pioneering research in applications of Far UV-C technology. With this funding, XCMR is poised to make significant strides in developing human-safe disinfection technologies that will enhance personal protective equipment and contribute to public health and safety.
